# Biowise Capital II, LLC — Form D/A

Biowise Capital II, LLC of DALLAS, TX, a pooled investment fund, filed a Form D amendment with the SEC on 2023-11-15. The offering totals $10.0M, of which $1.1M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2023-11-15
- Form: D/A
- Accession: 0001999472-23-000002
- Industry: Biotechnology
- Exemptions: 06c, 3C, 3C.1
- Total offering: $10.0M
- Amount sold: $1.1M
- Remaining: $8.9M
- Minimum investment: $50K
- Investors: 14
- Date of first sale: 2021-03-01
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-388670

## Issuer

- Name: Biowise Capital II, LLC
- CIK: 0001844785
- Entity type: Limited Liability Company
- Jurisdiction: TEXAS
- Incorporated: 2020
- Address: 100 CRESCENT COURT,, DALLAS, TX, 75201
- Phone: 214-810-4339

## Officers, directors & promoters (1)

| Name | Role | Location |
| --- | --- | --- |
| Amir Baluch | Executive Officer | Dallas, TX |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2021-02-08](https://search.stillhousedata.com/formd/0001844785-21-000001) | D | $10.0M | — |

## More

- [CIK 1844785 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1844785&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001999472-23-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.